XML 31 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments (Tables)
 12 Months Ended
Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]  
Schedule of lease payments

The Company is committed to lease payments as follows:

  

Fiscal year ending September 30,    
2018     $ 115,189  
2019       57,594  
      $ 172,783  
Schedule of purchase warrants outstanding

A summary of the status of the Company’s outstanding share purchase warrants is presented below:

 

    Number of Shares   Weighted Average Exercise Price
Balance, October 1, 2015       4,272,890     $ 2.11  
Exercised       (2,463,581 )   $ 1.67  
Balance, September 30, 2016       1,809,309     $ 2.70  
Exercised       (200,000 )   $ 3.00  
Balance,September 30, 2017       1,609,309     $ 2.66  
Schedule of exercisable share purchase warrants outstanding

At September 30, 2017, the Company had share purchase warrants outstanding of 1,609,309, with a weighted average exercise price of $2.66 as follows:\

 

Number   Exercise Price   Expiry Date
  1,262,180     $ 3.00     July 5, 2018
  30,000     $ 4.00     February 24, 2019
  277,127     $ 1.20     March 13, 2019
  1,252     $ 1.68     March 13, 2019
  31,250     $ 1.24     May 31, 2019
  7,500     $ 1.04     May 31, 2019
  1,609,309              
Schedule of outstanding stock purchase options

A summary of the status of Company’s outstanding stock purchase options is presented below:

 

      Number of
Shares		     Weighted
Average
Exercise Price		     Weighted
Average
Grant Date
Fair Value		  
Outstanding at October 1, 2015       1,822,500     $ 2.00          
Granted       2,401,500       5.22     $ 4.38  
Expired       (25,000 )     14.68          
Outstanding at September 30, 2016       4,199,000       3.76          
Granted       1,107,500       5.51     $ 5.44  
Forfeited       (214,470 )     4.06          
Outstanding at September 30, 2017       5,092,030     $ 4.13          
Exercisable at September 30, 2017       3,326,223     $ 3.10          
Exercisable at September 30, 2016       2,290,716     $ 2.42          
Schedule of stock options outstanding

At September 30, 2017, the following stock options were outstanding:   

 

Number of Shares               Aggregate     Remaining  
      Number     Exercise         Intrinsic     Contractual  
Total     Vested     Price     Expiry Date   Value     Life (yrs)  
500,000       500,000     $ 1.60     July 5, 2023   $ 1,270,000       5.76  
75,000       75,000     $ 1.20     May 7, 2024     220,500       6.60  
125,000       93,750     $ 1.32     May 8, 2024     352,500       6.60  
718,750       718,750     $ 0.92     April 2, 2025     2,314,375       7.50  
29,167       29,167     $ 1.44     June 8, 2025     78,751       7.69  
50,000       33,333     $ 1.76     June 15, 2025     119,000       7.71  
266,250       199,688     $ 5.04     September 18, 2025     —       7.97  
1,500       1,500     $ 5.64     September 30, 2025     —       8.00  
31,250       20,833     $ 5.68     October 2, 2025     —       8.01  
25,000       16,666     $ 8.98     October 16, 2025     —       8.04  
1,500       1,500     $ 5.57     December 31, 2025     —       8.25  
1,500       1,500     $ 4.90     March 31, 2026     —       8.50  
1,500       1,500     $ 5.66     April 27, 2026     —       8.57  
19,697       19,697     $ 4.09     May 18, 2026     985       8.63  
1,500       1,500     $ 6.11     June 30, 2026     —       8.75  
379,625       126,542     $ 6.26     July 5, 2026     —       8.76  
861,429       287,143     $ 7.06     July 18, 2026     —       8.80  
13,333       13,333     $ 3.06     September 7, 2026     14,400       8.94  
1,006,696       1,006,696     $ 3.28     September 22, 2026     865,759       8.98  
69,166       29,164     $ 3.63     October 3, 2026     35,275       9.01  
15,000       5,000     $ 4.35     December 9, 2026     —       9.19  
50,000       —     $ 5.39     February 7, 2027     —       9.36  
40,000       10,000     $ 5.26     February 17, 2027     —       9.38  
781,667       131,669     $ 5.92     May 12, 2027     —       9.61  
12,500       1,042     $ 3.42     August 9, 2027     9,000       9.86  
15,000       1,250     $ 4.33     September 19, 2027     —       9.97  
5,092,030       3,326,223                 $ 5,280,544          
Schedule of general and administrative expenses and research and development expenses

These amounts have been included in general and administrative expenses and research and development expenses on the Company’s statement of operations as follows: 

 

    2017   2016   2015
General and administrative   $ 2,017,199     $ 3,208,220     $ 1,633,979  
Research and development     2,118,371       1,854,047       —  
Total share based compensation   $ 4,135,570     $ 5,062,267     $ 1,633,979  
Schedule of weighted average assumptions for fair value of each option award

The fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following weighted average assumptions:

 

    2017   2016   2015
Risk-free interest rate     2.11 %     1.28 %     1.63 %
Expected life of options (years)     6.86       5.88       6.30  
Annualized volatility     111.58 %     114.75 %     98.41  
Dividend rate     0.00 %     0.00 %     0.00 %